{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:27Z","timestamp":1786119387967,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/coc.0b013e31815e3fdc","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T01:44:35Z","timestamp":1267062275000},"page":"300-305","source":"Crossref","is-referenced-by-count":81,"title":["Improvement, Clinical Course, and Quality of Life After Palliative Radiotherapy for Recurrent Glioblastoma"],"prefix":"10.1097","volume":"31","author":[{"given":"Carsten","family":"Nieder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina T.","family":"Astner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minesh P.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca L.","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Molls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210128","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-16-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/ctrv.2000.0191","article-title":"A comparison of treatment results for recurrent malignant gliomas.","volume":"26","author":"Nieder","year":"2000","journal-title":"Cancer Treatment Rev"},{"key":"R3-16-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.critrevonc.2006.06.007","article-title":"Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.","volume":"60","author":"Nieder","year":"2006","journal-title":"Crit Rev Oncol Haematol"},{"key":"R4-16-20210128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0167-8140(01)00299-7","article-title":"Reirradiation of primary brain tumours: survival, clinical response and prognostic factors.","volume":"59","author":"Veninga","year":"2001","journal-title":"Radiother Oncol"},{"key":"R5-16-20210128","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0360-3016(98)00457-X","article-title":"Reirradiation and lomustine in patients with relapsed high-grade gliomas.","volume":"43","author":"Arcicasa","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-16-20210128","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000061231","article-title":"Hyperfractionated reirradiation for malignant glioma.","volume":"33","author":"Nieder","year":"1999","journal-title":"Front Radiat Ther Oncol"},{"key":"R7-16-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11060-004-2463-y","article-title":"Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme.","volume":"74","author":"Combs","year":"2005","journal-title":"J Neurooncol"},{"key":"R8-16-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2407-5-55","article-title":"Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.","volume":"5","author":"Vordermark","year":"2005","journal-title":"BMC Cancer"},{"key":"R9-16-20210128","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0360-3016(98)00416-7","article-title":"A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.","volume":"43","author":"Hudes","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-16-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0360-3016(96)00455-5","article-title":"Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.","volume":"37","author":"Shepherd","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-16-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-006-9231-0","article-title":"Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma.","volume":"81","author":"Ernst-Stecken","year":"2007","journal-title":"J Neurooncol"},{"key":"R12-16-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-006-9283-1","article-title":"Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas.","volume":"82","author":"Kohshi","year":"2007","journal-title":"J Neurooncol"},{"key":"R13-16-20210128","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.ijrobp.2006.04.062","article-title":"Hypofractionated stereotactic radiotherapy combined with topotecan in recurrent malignant glioma.","volume":"66","author":"Wurm","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-16-20210128","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0360-3016(99)00336-3","article-title":"Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.","volume":"45","author":"Cho","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-16-20210128","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/cncr.21429","article-title":"Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme.","volume":"104","author":"Combs","year":"2005","journal-title":"Cancer"},{"key":"R16-16-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0360-3016(01)02804-8","article-title":"Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume.","volume":"53","author":"Simon","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-16-20210128","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ijrobp.2004.12.032","article-title":"Treatment of recurrent glioblastoma multiforme with gliasite brachytherapy.","volume":"62","author":"Chan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-16-20210128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1005710729748","article-title":"Verbally administered Barthel Index as functional assessment in brain tumor patients.","volume":"34","author":"Brazil","year":"1997","journal-title":"J Neurooncol"},{"key":"R19-16-20210128","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijrobp.2005.01.056","article-title":"Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)\/CT\/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.","volume":"63","author":"Grosu","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-16-20210128","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1227\/01.NEU.0000194836.07848.69","article-title":"GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.","volume":"58","author":"Gabayan","year":"2006","journal-title":"Neurosurgery"},{"key":"R21-16-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11060-006-9195-0","article-title":"Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme.","volume":"81","author":"Maier-Hauff","year":"2007","journal-title":"J Neurooncol"},{"key":"R22-16-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2005.05.024","article-title":"The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.","volume":"63","author":"Tsao","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-16-20210128","first-page":"29","article-title":"The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme.","volume":"9","author":"Ballman","year":"2007","journal-title":"Neurooncol"},{"key":"R24-16-20210128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/WNL.56.1.118","article-title":"PCV chemotherapy for recurrent glioblastoma multiforme.","volume":"56","author":"Kappelle","year":"2001","journal-title":"Neurology"},{"key":"R25-16-20210128","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1212\/01.WNL.0000140495.33615.CA","article-title":"How effective is BCNU in recurrent glioblastoma in the modern era?","volume":"63","author":"Brandes","year":"2004","journal-title":"Neurology"},{"key":"R26-16-20210128","first-page":"4727","article-title":"Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).","volume":"22","author":"Brandes","year":"2004","journal-title":"J Clin Oncol"},{"key":"R27-16-20210128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1006438109266","article-title":"A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas.","volume":"18","author":"Burch","year":"2000","journal-title":"Invest New Drugs"},{"key":"R28-16-20210128","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/cncr.11949","article-title":"Temozolomide in the treatment of recurrent malignant glioma.","volume":"100","author":"Chang","year":"2004","journal-title":"Cancer"},{"key":"R29-16-20210128","first-page":"33","article-title":"Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.","volume":"6","author":"Prados","year":"2004","journal-title":"Neurooncol"},{"key":"R30-16-20210128","first-page":"38","article-title":"Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme.","volume":"6","author":"Chua","year":"2004","journal-title":"Neurooncol"},{"key":"R31-16-20210128","first-page":"354","article-title":"Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.","volume":"9","author":"Kesari","year":"2007","journal-title":"Neurooncol"},{"key":"R33-16-20210128","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1200\/JCO.2005.03.2185","article-title":"Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.","volume":"23","author":"Reardon","year":"2005","journal-title":"J Clin Oncol"},{"key":"R34-16-20210128","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bjc.6603669","article-title":"Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).","volume":"96","author":"Franceschi","year":"2007","journal-title":"Br J Cancer"},{"key":"R35-16-20210128","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2006.06.2323","article-title":"Phase II trial of tipifarnib in patients with recurrent glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.","volume":"24","author":"Cloughesy","year":"2006","journal-title":"J Clin Oncol"},{"key":"R36-16-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90\u201305.","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000421-200806000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:11:24Z","timestamp":1786039884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-200806000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e31815e3fdc","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}